COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Monthly Archives:
May 2014

16

May
2014

category:

503b Compounding

Weekly FDA Enforcement Report For Drugs And Biologics 5/14/14

The Food and Drug Administration (FDA) has released its Drug and Biological product Enforcement Report for May 14, 2014. The agency publicizes recalls in its weekly report as press releases are not issued for all recalls. Manufacturers issue recalls voluntarily or the FDA initiates the action. View the recalls by Biologics or Drugs, and by Classification.  Classification I Recall […]

read more

16

May
2014

category:

503b Compounding

INDIA – Wockhardt recalls over 1 lakh bottles of hypertension drug in US

Drugmaker Wockhardt is recalling 1,09,744 bottles of a high blood pressure drug in the United States after it failed a dissolution test, the US Food and Drug Administration has said. The recall of metoprolol succinate began in April and was posted on the FDA website late Wednesday. Metoprolol succinate extended release is a cheaper generic form of […]

read more

15

May
2014

category:

503b Compounding

Generic Drug Economics at Root of Many Drug Shortages

The generic drug market’s economics have a particular impact on drug shortages, including shortages of critical drugs that may only be available in generic form, a report from the US Government Accountability Office (GAO) states. Most of the shortages within the past 2 years, including half of critical shortages, involve injectable generic drugs, GAO reports […]

read more